Journal Article
. 2019 Feb;37(9).
doi: 10.1200/JCO.18.01412.

Estimating Risk of Recurrence for Early Breast Cancer: Integrating Clinical and Genomic Risk

Mitch Dowsett 1 Nicholas Turner 1 
Affiliations
  • PMID: 30742561
  •     5 citations

No abstract available

TAILORx: Questions Answered, Lessons Learned, and Remaining Knowledge Gaps.
Joseph A Sparano, Robert Gray.
J Clin Oncol, 2019 Jun 08; 37(21). PMID: 31173552    Free PMC article.
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer.
Joseph A Sparano, Robert J Gray, +27 authors, George W Sledge.
N Engl J Med, 2019 Jun 04; 380(25). PMID: 31157962    Free PMC article.
Highly Cited.
Avoiding over- and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet?
A Matikas, T Foukakis, S Swain, J Bergh.
Ann Oncol, 2019 May 28; 30(7). PMID: 31131397    Free PMC article.
Review.
Simulation Modeling to Extend Clinical Trials of Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Early Breast Cancer.
Jinani Jayasekera, Joseph A Sparano, +5 authors, Jeanne Mandelblatt.
JNCI Cancer Spectr, 2020 Apr 28; 3(4). PMID: 32337487    Free PMC article.
Management of early breast cancer during the COVID-19 pandemic in Brazil.
Francisco Pimentel Cavalcante, Guilherme Garcia Novita, +4 authors, Ruffo Freitas Junior.
Breast Cancer Res Treat, 2020 Aug 18; 184(2). PMID: 32803637    Free PMC article.